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Abstract
Burn wounds result in varying degrees of soft tissue damage that are typically graded clinically. Recently a
key participant in neovascularization, the endothelial progenitor cell, has been the subject of intense cardiovascular
research to explore whether it can serve as a biomarker for vascular injury. In this review, we examine the identity of
the endothelial progenitor cell as well as the evidence that support its role as a key responder after burn insult. While
there is conflicting evidence with regards to the delta of endothelial progenitor cell mobilization and burn
severity, it is clear that they play an important role in wound healing. Systematic and controlled studies are
needed to clarify this relationship, and whether this population can serve as a biomarker for burn severity.
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Background
The nature and extent of burn injuries play important
roles in determining the body’s pathophysiological re-
sponse to this trauma. Approximately 450,000 people
seek medical treatment for burns every year in the
United States. Of these, approximately 40,000 are hospi-
talized, including 30,000 admissions to the 127 medical
centers that specialize in burn care [1]. The patho-
physiological response to thermal trauma is different
when compared to other forms of injury. One particular
element that is beginning to garner interest involves the
systemic mobilization of endothelial progenitor cells
(EPCs). Studies have shown that blood drawn from pa-
tients with burn wounds tend to have EPC counts which
deviate significantly from typical basal concentrations
[2–4]. Examining the correlation between human EPC
levels and burn injury could indicate whether EPC
counts are related to recovery time, potentially serving
as an indirect parameter for injury severity as well as an
indicator for survival [2–4].
The study of EPCs and their role in vasculogenesis has
increased exponentially since Asahara et al. first de-
scribed the isolation of cells from both human and
mouse peripheral blood that contribute to endothelial
cell (EC) formation and postnatal neovascularization [5].
Increasingly, evidence is mounting for the use of circu-
lating EPCs as a biomarker for various diseases. For ex-
ample, a recent study demonstrated that EPC numbers
and function are significantly decreased in children diag-
nosed with systemic lupus erythematosus (SLE) when
compared to patients with juvenile idiopathic arthritis
and matched control subjects. Mohan et al. suspect the
vascular damage observed in these patients is triggered
by type I interferons, as is seen in patients with adult-
onset SLE [6]. In the setting of oncogenesis, tumor de-
velopment and metastasis is dependent on a sustained
vascularization capability. As such, numerous studies
have demonstrated that circulating EPCs directly correlate
with tumor stage, size, microvessel density, and serum vas-
cular endothelial growth factor (VEGF) concentration [7].
Extensive research has also shown that in the setting of is-
chemic brain injury, circulating EPC levels correlate with
neurovascular remodeling and repair via paracrine mecha-
nisms as well as direct differentiation [8]. Currently, the vast
majority of EPC biomarker research is being conducted in
cardiovascular medicine. Specifically, the conditions that
comprise metabolic syndrome including coronary artery
disease [9] and diabetes mellitus [10], have been consist-
ently associated with fewer circulating EPCs [11].
The evidence with regards to EPC mobilization follow-
ing trauma, and particularly thermal injury is less clear.
Early studies have reported an immediate release of
EPCs into the bloodstream of human patients after burn
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insult that is strongly correlated to the depth and extent
of the burn [3, 12]. More recently, Zhang et al. used a
systematic approach to induce burn wounds in mice and
observed systemic mobilization of EPCs that negatively
correlated with the severity of the burn both in terms of
time and magnitude [13]. Subsequently, the same group
at Johns Hopkins has conducted a number of in vitro
studies implicating hypoxia-inducible factor 1α (HIF-1α)
and its downstream mediators as critical to the deploy-
ment and recruitment of EPCs [14–16].
Regardless of their response, EPCs have a clear role in
postnatal vasculogenesis and thus, the correlation between
EPCs and burn injury depth represents a potential thera-
peutic target and/or diagnostic for the treatment of ther-
mal injuries [17]. Burn injuries typically result in damage
to the vasculature. Therefore, our group is interested in
exploring the relationship between EPC mobilization/
homing and vascular injury. Restoration (angiogenesis) or
de novo formation (vasculogenesis) of the vascular net-
work lost after burn trauma is necessary for the delivery of
oxygen-rich blood containing the cellular response needed
for prompt healing. However, before exploring this rela-
tionship, one must first look at the various characteristics
used to define EPCs in the literature.
Review
Defining EPCs and circulating angiogenic cells
In general, endothelial progenitor cells have been defined
as circulating cells that express cell surface markers similar
to those found on vascular endothelial cells, adhere to the
endothelium at sites of hypoxia and ischemia and partici-
pate in new vessel formation [18]. The term ‘progenitor’
connotes that an EPC will eventually become a mature EC,
enabling direct contribution to the formation of vascular
tissue. Recent evidence, however, suggest that the term
‘endothelial progenitor cell’ may be a misnomer for this
broadly defined population that exists in the bone marrow,
circulation and in the local tissue microenvironment
(Fig. 1).
Prior to 1997, postnatal angiogenesis was thought to be
solely carried out by the migration of mature ECs while
vasculogenesis occurred through angioblast-induction of
hematopoietic stem cells (HSCs) [19]. This view changed
when Asahara et al., utilizing a new method for the isola-
tion of bone marrow-derived progenitor cells from human
and mouse peripheral blood, demonstrated that these cells
were capable of differentiating into endothelial cells and
promoting neovascularization [5]. This group used mag-
netic beads to isolate cells that were positive for both
CD34 and vascular endothelial growth factor 2 receptor
(KDR), two markers that are highly expressed on activated
ECs as well as HSCs [5]. While this marker combination
became the standard for EPC selection by many through-
out the field, this strategy was often criticized for its lack
of CD45 investigation, whose presence indicates a
hematopoietic identity [18].
Philosophically, a true ‘endothelial progenitor’ must in-
clude certain properties such as the ability to give rise to
progeny displaying clonal proliferative potential, a differ-
entiation capacity restricted to the endothelial lineage,
and the ability to form lumenized capillary-like tubes in
vitro. These cells must also possess the ability to form
stable blood vessels in vivo that integrate into the host
circulatory system once implanted [18]. The distinction,
however, between the circulating cells that mature into
ECs and those that indirectly contribute to neovasculari-
zation via paracrine mechanisms may not be necessary
for the purposes of human clinical evaluation.
Early in vitro work on the peripheral blood mono-
nuclear cells (MNCs) first described by Asahara et al.
demonstrated that these cells (e.g., CD34+/CD133+/KDR+),
though expressing various endothelial markers, also
exhibit a number of myeloid/hematopoietic characteris-
tics including the presence of CD45, CD14 and CD11b
[11, 18, 20]. Despite this seemingly contradictory iden-
tity, these cells have been shown to exhibit proangio-
genic activity such as participating in the restoration of
blood flow in a murine ischemic hindlimb model, as well
as improving cardiac outcomes in human patients after
acute myocardial infarction [21]. Additional characteris-
tics, such as the ability of these cells to bind acetylated
low-density lipoprotein (acLDL) and lectin, have also
been used to identify EPCs, but have proven to be non-
specific for a progeny that results in a true endothelial
state [18]. In contrast, it has been proposed that only the
CD34+/CD45- subset possesses the ability to progress to
mature ECs [18]. To this point, Asahara et al. recently
proposed that there are two subsets of endothelial pro-
genitor cells: hematopoietic EPCs which are related to
and derived from the same precursors as HSCs and
nonhematopoietic EPCs, both of which contribute to
postnatal neovascularization [22]. Thus, both can be
classified as “circulating angiogenic cells” (CACs) when
recovered from the bloodstream.
The pathway of EPC mobilization and homing is a
complex one that is not fully understood. In the setting
of burn injury, ischemia is the driving force behind EPC
localization which is orchestrated by the upregulation of
transcriptional factor HIF-1α [14–16]. Activation of this
pathway leads to the expression of the key ligand stro-
mal cell-derived factor 1α (SDF-1α) and its receptor
CXC chemokine receptor 4 (CXCR4) [2, 11, 14–16, 23].
However, other factors strongly implicated in this
process include VEGF, granulocyte colony stimulating
factor, metalloproteinase 9, hepatocyte growth factor,
and erythropoietin [24]. Once at the sight of injury, non-
hematopoietic EPCs are thought to directly contribute
to neovascularization by attachment and maturation into
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ECs, while hematopoietic EPCs contribute via paracrine
signaling through the secretion of the cytokines such as
VEGF, SDF-1α, hepatocyte growth factor, insulin-like
growth factor, endothelial nitric oxide synthase and
inducible nitric oxide synthase [22] (Fig. 1) .
EPCs in relation to burn depth and severity (Table 1)
In 2001, Gill et al. provided evidence that in humans,
burn trauma results in a rapid release of VEGF that
leads to a significant, but transient mobilization of
CD133+/KDR+ cells, termed endothelial precursor cells,
which usually returns to baseline after one to two days
[12]. However, it was Fox et al. that first examined the
relationship between EPC mobilization and burn sever-
ity. They collected blood from control patients as well as
those who sustained superficial (n = 15) and full thick-
ness (n = 4) burns at 24-hour time points for 3 days. The
focus of their analysis was on nonhematopoietic EPCs
based on a flow cytometry phenotyping protocol which
quantified the CD45dim/-/CD133+/CD144+/KDR+ cells.
This group observed a rapid and significant rise in sys-
temic EPC levels that peaked within the first 24 h and
correlated with burn depth severity. The statistically sig-
nificant rise in EPC levels diminished after 48 h but was
also strongly correlated with higher levels of VEGF and
SDF-1α in the plasma that persisted for three days [3].
A group from Germany has also provided some clues re-
garding how MNC and EPC mobilization correlates with
extent of burn injury. In their initial study, Piatkowski et
al. collected blood samples at various time points during
the first 5 days of hospitalization from 17 individuals who
sustained burns ranging from 15 to 84 % total body surface
area (TBSA) and compared it with 17 age-matched con-
trols. They observed a significant rise in MNC counts on
admission and at day 5, and these counts directly
Fig. 1 Proposed endothelial progenitor cell (EPC) involvement after burn injury. Burn insult and resulting hypoxia/ischemia lead to the
upregulation of HIF-1α which promotes VEGF and SDF-1α secretion as well as increased CXCR4 expression on EPCs. VEGF is primarily responsible
for the proliferation of hematopoietic EPCs (local tissue environment/blood stream) and non-hematopoietic EPCs (bone marrow) while SDF-1α
promotes transendothelial migration into the bloodstream and soft tissue as well as adhesion at the site of tissue injury. Hematopoietic EPCs
contribute to burn injury through direct attachment, maturation to endothelial cells and the formation of new vascular tissue, while non-hematopoietic
indirectly aid in this formation through the secretion of various cytokines
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correlated with the extent of the TBSA of the burns. How-
ever, their analysis of EPC levels, which did not distinguish
between hematopoietic and nonhematopoietic lineages
(CD34+/KDR+/acLDL+/lectin+), demonstrated significantly
lower EPC counts in burn patients when compared to the
control group on admission. These levels did slowly rise,
however, and reached statistical significance at day five ex-
cept in those patients who did not survive. Notably, the
most extensive burns (>25 % TBSA) were associated with
significantly lower CAC levels when compared to those
suffering less extensive burns [25].
This group went further when they described the first sys-
tematic porcine model for EPC mobilization after burn in-
jury. Groger et al. quantified systemic MNC and EPC levels
in pigs after subjecting them to 30 % TBSA full-thickness
burns. They consistently observed a significant bimodal drop
in MNC counts during the burn and at 12 h post-burn. The
EPC count also dropped during the burn insult, but rapidly
returned to baseline levels at 2 h and remained stable for the
remainder of the 48 h post-burn observation period [26].
This study did not, however, examine whether EPC
mobilization varies with the extent or depth of burn and is
therefore limited in its ability to predict any correlations.
Using an innovative approach, Pan et al. closely examined
burn blister fluid and resident human tissue from the sites
of superficial (SPTBs) and deep partial thickness burns
(DPTBs), classifications which serve as surrogate markers
for burn severity. From a histological standpoint at day 7
post-burn, dermal tissue harvested from DPTBs demon-
strated vast amounts of vascularity that was absent from
the SPTB dermal tissue. In an in vitro transwell migration
assay using burn blister fluids collected from the first 3 days
post-burn, it was found that DPTB fluid induced significant
mobilization of MNCs when compared to SPTB fluid and
control media. And while burn blister fluid did not improve
the KDR or von Willebrand factor (vWF) mRNA expres-
sion in ECs over control media, DPTB fluid was signifi-
cantly superior to the other experimental conditions at
promoting CAC differentiation from MNCs [27]. This
study suggests that deeper burns are characterized by in-
creased neovascularization over more superficial burns, and
that factors present at the burn wound interface are likely
involved in the recruitment and differentiation of CACs.
Similar to the group from Germany, Zhang et al. employed
an animal model to systematically quantify CAC response to
burn injury. These researchers analyzed the degree of murine
CACmobilization as it relates to burns of varying depth. They
found an indirect correlation between burn depth severity
and CAC mobilization as well as tissue perfusion, linking the
two in the pathophysiological response to burn healing [13].
Thus, they postulate that deeper, more severe burns heal at
delayed rates due to a lack of CACs, which in turn results in
decreased angiogenesis and healing. Subsequently, this same
group at Johns Hopkins sought to identify possible mecha-
nisms underlying the delayed burn wound healing observed
in elderly patients. In a mouse full-thickness burn wound
Table 1 Studies evaluating CACs in burn patients
Study CAC characterization Assessed correlation to
burn depth severity?
Key findings
Gill et al.,
2001 [12]
CD133+/KDR+/CD15− No Patients with > 15 % TBSA Burn→↑VEGF systemically (at 6–12 h) which
was followed by transient mobilization of CACs that peaked at 12 h and
returned to baseline at 24–48 h.
Fox et al.,
2008 [3]
CD45dim/-/CD133+/CD144+/KDR+ Yes All pts with burns exhibited a significant rise in CACs that peaked at
24 h and returned to baseline after 72 h. There was a positive correlation
between level of CACs and percent TBSA of burn. CAC levels also correlated
strongly with VEGF & SDF-1α levels.
Piatkowski et al.,
2009 [25]
CD34+/KDR+/acLDL+/lectin+ Yes Significantly lower CAC count in pts with extensive burns (>25 % TBSA)
than those with smaller burns (10–24 %) on admission. CAC levels rose
in all burn pts, with extensive burn pt CAC levels not reaching a significant
level until day 5 except in pts who did not survive.
Groger et al.,
2010 [26]
CD34+/KDR+/acLDL+ No (animal model) All animals sustained 30 % TBSA burn. Observed significant CAC drop
during burn insult followed by rapid increase to ½ baseline levels at 2 h
that remained stable for 48 h.
Pan et al.,
2010 [27]
CD31+/KDR+/acLDL+ Yes Ex vivo analysis of burn fluid demonstrated stronger paracrine signaling
for MNC recruitment and CAC differentiation in DPTB fluid when compared
to SPTB fluid.
Zhang et al.,
2010 [13]
acLDL+/lectin+ Yes (animal model) ↑CACs in all burn groups, but day and magnitude of mobilization inversely
proportional to degree of burn insult.
Foresta et al.,
2011 [2]
CD45+/CD34+/CD133+/KDR+ No Significant drop in CACs in burn pts on admission compared to control.
Significant release in CACs both at day 1 and 12 not observed in control
group.
Abbreviations: CAC circulating angiogenic cell, KDR kinase insert domain receptor (VEGFR-2), acLDL acetylated low-density lipoprotein, TBSA total body surface
area, MNC mononuclear cell, SPTB superficial partial-thickness burn, DPTB deep partial-thickness burn, VEGF vascular endothelial growth factor, SDF-1α stromal
derived factor 1α
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model, they noted that older mice suffered delayed burn
wound healing when compared to younger mice, and this
was conferred by impaired mobilization of EPCs expressing
CXCR4 as well as decreased systemic levels of levels of
HIF-1α and SDF-1α [16]. This group went further by dem-
onstrating that HIF-1α knockout mice suffer significant de-
lays in burn wound healing that are associated with
decreased mobilization of EPCs [15], and the addition of
stabilized HIF-1α and EPCs led to rapid closure of these
wounds in older mice compared to control [14].
Foresta et al. also examined the mobilization of CACs in
patients suffering burns ranging from 15 to 57 % TBSA.
While the study did not compare CAC mobilization to
extent of burn insult, this group reported data up to
30 days post-injury. The hematopoietic EPC population
(CD45+/CD34+/CD133+/KDR+) was quantified both on
admission and at various time points during the study.
Interestingly, they observed a bimodal distribution of CAC
mobilization. The first peak was observed on day 1, similar
to the findings of Fox et al., while the second and peak of
greatest magnitude was seen on day 12, which they believe
was associated with the escharectomy that all patients re-
ceived on day 5 or 6. Similar to most other studies
reviewed, this group observed a significant drop in admis-
sion CAC counts in the burn patients when compared to
control.
Future considerations: standardization of clinical assays
and patient selection
The biggest impediment to conducting effective research
on the role of CACs as a biomarker for burn severity is the
lack of consensus with regards to phenotypic and physio-
logical definitions. Despite this, one would find it difficult to
dispute the role of the EPCs in neovascularization. For in-
stance, Rignault-Clerc et al. isolated peripheral blood MNCs
from individuals who sustained > 10 % TBSA burns within
the first 24 h of hospitalization. This group used special cul-
ture techniques to obtain late outgrowth EPCs from both
control and burn patients. These nonhematopoietic CACs
are associated with the ability to directly contribute to ves-
sel formation through their differentiation into mature ECs
while lacking paracrine function. They found that late out-
growth EPCs from burn patients demonstrated significantly
higher levels of VEGF secretion. However, this VEGF ad-
vantage did not necessarily translate into a clinical benefit
as injection of these EPCs from both burn and control pa-
tients were equally effective at improving perfusion recov-
ery in a murine model of hind limb ischemia [4].
Various methods were used to identify CACs in the studies
reviewed. Most commonly, KDR was used in combination
with either CD34 or CD133 to positively identify CACs [2–4,
12, 25, 26]. While either combination stain is sufficient for
the identification of CACs, KDR+/CD34+ cells will be de-
tected at ~200 times greater frequency than KDR+/CD133+,
as CD133 denotes a more primitive progenitor phenotype
[19]. And while other studies used acLDL and lectin positiv-
ity to identify CACs, this methodology is less practical for
clinical translation as these assays require a cell culture step.
KDR and CD34 are cell surface markers that can be easily
quantified after isolating peripheral venous bloodMNCs and
analyzing with a flow cytometer. Lastly, we believe that CD45
should be excluded from the analysis of CACs. While this
marker allows for the identification of hematopoietic versus
nonhematopoietic CACs, we feel this distinction is unneces-
sary as both population of cells contribute to neovasculariza-
tion [22] (Fig. 1) .
In terms of mobilization and recruitment, it appears
that HIF-1α, VEGF and SDF-1α are most important for
CACs [2, 3, 14–16]. It has been suggested that VEGF is
more responsible for EPC proliferation, mobilization,
adhesion and incorporation into damaged vessels
while SDF-1α is primarily attributed to the facilitation
of transendothelial migration and the induction of
specific adhesion molecules [2]. Both of these cyto-
kines are regulated by HIF-1α, which has clearly been
demonstrated to show a significant role in burn
wound healing in vitro [14–16]. Recently, angiogenin
has been demonstrated to be a key paracrine signaler
in superficial and deep partial-thickness burns for the
promotion of neovascularization. Pan et al. demon-
strated that angiogenin alone was able to induce CAC
differentiation into ECs in the absence of VEGF-A,
and that its absence was associated with a significant
reduction in EC proliferation and new blood vessel
formation in vivo [28].
One stark limitation in studying CAC mobilization as
a biomarker for burn injury is the variability of patient
co-morbidities and temporal relationship of the burn in-
sult to the presentation to a tertiary facility for analysis.
As evidenced by the first systematic animal-controlled
study that measured blood levels during burn insult,
thermal injury is associated with an immediate decline
in CAC level [26]. This is a finding that was recently
buttressed by Maluegha et al. who showed that mice
subjected to electrical burns experienced an increase in
VEGF and nitric oxide along with a simultaneous de-
crease in EPC counts [29]. From a clinical perspective,
Foresta et al. and Piatkowski et al. observed declines in
CACs of human patients on admission after burn insult
[2, 25], however, where Piatkowski et al. didn’t observe a
significant increase in CACs versus control throughout
their study [25], Foresta et al. eventually observed a
significant rise in CAC counts [2].
Whether there is a delay or immediate release, a number
of studies report the eventual and significant mobilization
of CACs in response to burn injury [2, 3, 12, 13]. And
while some studies report this deployment as an isolated
and transient event limited to the first 24–48 hours [3, 12],
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there is evidence that a secondary mobilization can occur
as late as 12 days post-burn insult [2].
Clinically, elderly patients exhibit retarded wound heal-
ing after burns. The group at Johns Hopkins demonstrated
that this mechanism of delayed and suboptimal healing is
primarily mediated by the HIF-1α pathway and poorly
functioning EPCs [14–16]. Based on the lack of age strati-
fication and extreme variability in burn severity of the clin-
ical studies presented here, there is reason to believe that
there are various factors effecting CAC mobilization that
have yet to be elucidated. In light of these complex and
varied findings, it is clear that more research is needed in
this arena.
Conclusions
Endothelial progenitor cells comprise various cell popula-
tions that are CD34+/KDR+ and exist in the bone marrow,
local tissue microenvironment and circulation. As has
been evidenced in the cardiovascular literature, systemic
levels of these cells likely reflect local tissue injury, espe-
cially in the setting of thermal trauma. While evidence is
conflicting at this point, the use of CACs as a biomarker
of degree of burn insult is promising. Further controlled
and highly-powered studies are required to elucidate this
relationship.
Abbreviations
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